RedHill Biopharma

RedHill Biopharma is focused primarily on the acquisition and development of late clinical-stage formulations of existing drugs.

RedHill Biopharma, established in 2009, is a pharmaceutical company focused primarily on acquisition and development of late clinical-stage new, improved and patented formulations of existing drugs, with preference to a 505(b)(2)* regulatory paths, as well as acquisition and developement of late clinical-stage, new and patented orphan drugs.